Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Carbylan Therap Cmn (CBYL)

Carbylan Therap Cmn (CBYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Carbylan Therap Cmn 39899 Balentine Drive Suite 200 Newark CA 94560

www.carbylan.com P: 510-933-8365

Description:

Carbylan Therapeutics, Inc. is a specialty pharmaceutical company which focused on the development and commercialization of combination therapies that address unmet medical needs. The Company's product candidate consists of Hydros-TA, which is in clinical trial to treat pain associated with osteoarthritis of the knee. Carbylan Therapeutics, Inc. is headquartered in Palo Alto, California.

Key Statistics

Overview:

Market Capitalization, $K 18,130
Shares Outstanding, K 26,340
Annual Sales, $ 30 K
Annual Net Income, $ -24,850 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -2,390 K
60-Month Beta 2.47
% of Insider Shareholders 26.10%
% of Institutional Shareholders 34.13%

Growth:

1-Year Return -80.85%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/09/16
Earnings Per Share ttm -0.81
EPS Growth vs. Prev Qtr 67.86%
EPS Growth vs. Prev Year 52.63%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CBYL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.21%
Return-on-Assets % -48.80%
Profit Margin % -82,833.34%
Debt/Equity 0.00
Price/Sales 625.08
Price/Cash Flow N/A
Price/Book 0.53
Book Value/Share 1.29
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar